Giuseppe Curigliano: Lillian Siu continues to inspire and drive advancements in oncology

Giuseppe Curigliano shared on LinkedIn:

“Congratulations to Lillian Siu, the recipient of the ASCO24 Karnofsky Award! Her pioneering work in cancer research continues to inspire and drive advancements in oncology. A well-deserved honor for a true leader!”

Source: Giuseppe Curigliano/LinkedIn

Giuseppe Curigliano, MD, PhD, is the Director of the Early Drug Development Division and co-chairs the Experimental Therapeutics Program at the European Institute of Oncology. He is a member of the Department of Oncology and Hemato-Oncology’s steering committee at the University of Milan and serves on the Italian National Health Council, advising the Ministry of Health on cancer policy issues.

Lillian Siu is a leading cancer specialist in the field of oncology and drug development. Dr. Siu is a Professor of Medicine at the University of Toronto and serves as a senior medical oncologist at the Princess Margaret Cancer Centre, University Health Network. She is the President-Elect of the American Association for Cancer Research (AACR) for 2024-2025.